William Troutman in a hospital chair receives IV treatment. He holds up seven fingers to mark his seventh day of treatment.

Delaying a T1D diagnosis with Tzield: “A deep sigh of relief, for a little while”

[podcast src=”https://html5-player.libsyn.com/embed/episode/id/26140521/height/360/theme/custom/thumbnail/no/direction/forward/render-playlist/no/custom-color/26a9e0/” width=”100%” scrolling=”no” class=”podcast-class” frameborder=”0″ placement=”top” primary_content_url=”http://traffic.libsyn.com/diabetesconnections/Ep_551_Final_Tzield_Troutman.mp3″ libsyn_item_id=”26140521″ height=”360″ theme=”custom” custom_color=”26a9e0″ player_use_thumbnail=”” use_download_link=”use_download_link” download_link_text=”Download” /]Last fall, Tzield was approved to delay type 1 diabetes in people predicted to develop it. This week, I’m talking one of the first families to use what used to be called Teplizumab for their son, as a regular patient,…